Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Immunol
Hauptverfasser: Jacque, Emilie, Chottin, Claire, Laubreton, Daphné, Nogre, Michel, Ferret, Cécile, de Marcos, Sandrine, Baptista, Linda, Drajac, Carole, Mondon, Philippe, De Romeuf, Christophe, Rameix-Welti, Marie-Anne, Eléouët, Jean-François, Chtourou, Sami, Riffault, Sabine, Perret, Gérald, Descamps, Delphyne
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Immunology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215542/
https://ncbi.nlm.nih.gov/pubmed/34163482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.683902
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge